Ricardo Cohen (@rvcohen) 's Twitter Profile
Ricardo Cohen

@rvcohen

Presidente IFSO World . Cirurgia da Obesidade e Diabetes/MD- Bariatric and Metabolic Surgery

ID: 37121826

calendar_today02-05-2009 02:55:01

4,4K Tweet

2,2K Takipçi

1,1K Takip Edilen

Ricardo Cohen (@rvcohen) 's Twitter Profile Photo

model says tirzepatide is cost-effective but only by assuming: 📌 5 years of perfect adherence 📌 Benefits persist long after stopping- not proven 📌 Discounted drug prices (not what payers actually pay) 📌 A 30y time horizon Real-world? Much less certain